Isocitrate lyase catalyzes the diversion of isocitrate to the glyoxylate cycle at the metabolic branch point that alternatively leads to the tricarboxylic acid (TCA) cycle. The glyoxylate cycle enables an organism to bypass the two oxidative C02-forming steps of the TCA cycle when converting isocitrate to malate and succinate (11, 12) . Thus, it conserves carbon while enabling an organism to convert fatty acids to carbohydrates and maintain an adequate supply of TCA cycle intermediates for biosynthetic purposes. For organisms whose only source of carbon is fatty acids, an active glyoxylate cycle is necessary for growth. This cycle is present in bacteria, fungi, oil-rich higherplant seedlings, parasitic invertebrates, and some insects (for a review, see reference 22) .
Isocitrate lyase has been characterized from a number of sources and usually is a tetrameric enzyme which requires a divalent metal, preferably magnesium, and a thiol, such as dithiothreitol, for activity in vitro. Isocitrate lyase from Escherichia coli has been shown to be phosphorylated on a histidine residue in the active form (19) . The proposed catalytic mechanism for this enzyme involves acid-base catalysis in which DS-isocitrate is deprotonated by isocitrate lyase, leading to glyoxylate and the succinate anion, which is then protonated to complete the reaction (22) .
The amino acid sequence for isocitrate lyase has been derived from eight different organisms. An inspection of the alignment and a comparison of these derived sequences reveal several features (6) . Particularily evident is a 112-to 137-amino-acid stretch which is present only in the eukaryotic sequences and which may function in targeting isocitrate lyase to perioxisomes, in which it is found in eukaryotes. In addition, four highly conserved regions (E. coli isocitrate lyase residues 177 to 201, 231 to 241, 310 to 324, and 348 to 356) are evident in the aligned sequences. The first region contains two completely conserved lysines, 193 and 194, and two completely conserved histidines, 184 and 197 (Fig. 1) (6) . In addition, affinity labeling studies with bromopyruvate have chemically modified the conserved Cys-195 residue, indicating that this residue is located in the active-site domain of the enzyme (9) . Accordingly, substitution of this residue with Ser also inactivates the enzyme (6) . Other chemical studies with diethyl pyrocarbonate have indicated that His-266 and His-306 may be active-site residues. Although these residues are not highly conserved, saturation kinetics with respect to inactivation were observed, and the substrate protected these residues from modification (10) . The present study investigates the role of some of the identified histidines present in the E. coli enzyme by site-directed mutagenesis. In particular, the two highly conserved histidine residues present in the first conserved region of the enzyme, His-184 and His-197, and the two diethyl pyrocarbonate-modified residues, His-266 and His-306, have been changed.
Histidines selected for mutation. The histidines at positions 184 (H-184) and 197 (H-197) were selected because they are present in the first highly conserved region of the aligned isocitrate lyase enzymes. These two residues were changed to lysine (K), arginine (R), leucine (L), and glutamine (Q). Two other histidine residues, H-266 and H-306, were selected for mutation because diethyl pyrocarbonate modification indicated that they are in the active-site domain of the enzyme (10 H-184, H-197, and H-306 residues was done by unique restriction enzyme site elimination (5) with a Transformer mutagenesis kit (Clontech Laboratories) as described by Diehl and McFadden (6) . This is a two-primer technique which enables the mutagenesis of double-stranded DNA. The H-266 residue was mutated by dut-ung mutagenesis with a Muta-Gene M13 mutagenesis kit (Bio-Rad Laboratories) (13) . For this technique, a section of the aceA gene from 787 to 1,307 bp and containing the codon for H-266 was excised from plasmid pICL1 by digestion with HaeIII. This fragment was ligated into the SmaI site of M13mpl8 to create M13mp18/H266-aceA. E. coli CJ236 (dut ung thi-1 rel41; containing pCJ106 [Cmr] ) was used to produce phage containing single-stranded M13mpl8/ H266-aceA DNA, which was isolated and used for in vitro mutagenesis. Plaques resulting after transformation of E. coli MV1190 [A(lac-proAB) thi supE A(srl-recA)306::TnlO (F' traD36 proAB lacIqZAM15)] by the in vitro mutagenesis reaction were used to isolate mutated DNA. After identification, double-stranded (replicative-form) M13mpl8/H266-aceA DNA and pICL1 DNA were digested with restriction enzyme DsaI. The DsaI fragment from M13 containing the mutated H-266 codon was transferred back into plasmid pICL1. The resulting mutated pICLI DNA was used to transform E. coli JE10 (AaceA recA::TnlO) cells (15) . Finally, plasmid pICL1 with the double mutant, H266E/H306E, was created by swapping the DsaI fragment containing the H-266 mutation for the wild-type fragment in plasmid pICL1 containing the H-306 mutation. All mutations were verified by dideoxynucleotide sequencing.
Isocitrate lyase assay. High-speed supernatant fractions of cell lysates prepared from cultures of isocitrate lyase-deficient E. coli JE10 expressing the wild-type enzyme, the mutated enzyme, or an inactive form (because of a 400-bp aceA deletion) of isocitrate lyase were used for isocitrate lyase assays as described by Diehl and McFadden (6) . In brief, after induction of expression with isopropyl-13-D-thiogalactopyranoside (IPTG), JE10 cells expressing plasmid pICL1 containing either wild-type aceA or a mutant form of aceA in 200-ml cultures in Luria-Bertani medium (21) with 150 ,ug of ampicillin per ml were lysed by freezing-thawing in 3 ml of lysis buffer (50 mM Tris-HCl, 1 mM EDTA, 100 mM NaCl [pH 8.0]) containing 0.08 mg of lysozyme. After thawing and centrifugation for 1 h at 220,000 x g in isocitrate lyase assay buffer (0.05 M morpholine propanesulfonic acid [MOPS], 5 mM MgCl2, 1 (17, 18) showed that assembly into the tetrameric complex characteristic of the wild-type enzyme either did not occur or was extremely limited for the H-184 mutant proteins, including the H184Q variant with low activity (Fig. 2) . Hence, changes in this residue interfere with the assembly of the monomeric subunits (15) into the tetrameric enzyme. All the other mutant proteins, including the marginally active H-197 series, migrated like the wild-type tetramer in nondenaturing PAGE (Fig. 2) seems that, of these three cationic residues in the first conserved region, H-184 is involved in the assembly of the tetrameric complex, H-197 is involved in catalysis, and K-193 has a major role in catalysis but is also significant in substrate binding.
None of the five H-266 mutations nor the four H-306 mutations resulted in enzymes which markedly differed kinetically from the wild type (Table 1) . Even changes resulting in substantial charge and/or steric pertubations, such as substitution with valine or glutamate, did not affect enzyme activity. These results indicate that neither H-266 nor H-306 requires phosphorylation for enzyme activation, nor does either appreciably contribute to catalysis by the enzyme. This latter result is surprising in light of the study of Ko et al. (10) , in which carboxyethylation by diethyl pyrocarbonate of these residues was shown to inactivate isocitrate lyase. Because in the diethyl pyrocarbonate study both H-266 and H-306 were modified, a double mutant of isocitrate lyase in which glutamate was substituted for both H-266 and H-306 was constructed. The H266E/H306E mutation decreased enzyme activity by 60% (Table 1) , simply the amount expected when the slight effects on the activity of the two separate mutations are added together.
The apparent conflict between the present study and the carboxyethylation of H-266 and H-306 in the study of Ko et al. (10) (22), could then attack the hemimercaptal carbon of glyoxylate, and the thiolate anion would act as an effective leaving group, especially when facilitated by reformation of the ion pair shown. Although not shown, the actual substrate is probably Mg2+-isocitrate (22) . As Growth of isocitrate lyase-deficient E. coli JE10 cells expressing isocitrate lyase mutants. Tests of the growth of E. coli JE10 in minimal acetate medium while expressing various mutations of isocitrate lyase from plasmid pICL1 were conducted as described by Diehl and McFadden (6) . In brief, 0.4 ml of stationary-phase cultures of JE10 were diluted to an optical density at 600 nm of 0.05 and then were added to 5 ml of M9 minimal (21) medium supplemented with 0.2% glucose or acetate, 100 plg of ampicillin per ml, and 20 ,ug of tetracycline per ml. After growth at 37°C, doubling times were determined by inspection of the linear portion of a plot of log optical density at 600 nm versus time.
In minimal glucose medium, the rates of growth of E. coli JE10 expressing any of the isocitrate lyase variants were similiar (doubling times, ca. 1.5 h at 37°C). In minimal acetate medium, both E. coli JE10 expressing wild-type isocitrate lyase from pICL1 and E. coli JM105 (the aceA+ parental strain for JE10) (15) , since this nearby conserved residue has been placed in the active site by affinity labeling with the substrate analog bromopyruvate (9) and substitution of this residue with Ser results in an inactive enzyme in vitro (6) . With regard to an interaction between the side chains of , the mechanism established for the thiol proteases is enlightening (4, 7) . In these proteases, the imidazole group of the histidine is protonated by the thiol hydrogen from the proximal active-site cysteine, forming an ion pair. The thiolate anion then acts as a nucleophile to form a tetrahedral intermediate prior to the peptide cleavage reaction. In the case of isocitrate lyase, a similiar interaction may occur (Fig. 3) . The thiolate anion may form a tetrahedral intermediate, a hemimercaptal, of glyoxylate in the condensation reaction. Our data suggest that the thiolate form of the enzyme is not obligatory in forming the hemimercaptal but that the parent thiol can also form the tetrahedral intermediate, as would be expected, but at a rate 300 to 400 times slower (Table 1 ). It is clear that the "crippled" enzyme functions reasonably well in supporting E. coli JE10 growth on acetate. Elucidation of the crystal structure of isocitrate lyase, which is in progress (1) , should help test this proposed mechanism.
